IRS1 phosphorylation underlies the non-stochastic probability of cancer cells to persist during EGFR inhibition therapy.
Ontology highlight
ABSTRACT: IRS1 phosphorylation underlies the non-stochastic probability of cancer cells to persist during EGFR inhibition therapy.
PROVIDER: PRJNA741779 | ENA |
REPOSITORIES: ENA
ACCESS DATA